July 03 2018 | 0 Comments | 74 reads Average Rating: 3

Flipping the Switch: How Life Sciences Companies Can Help Providers See Care in a New Light

by John Pagliuca in Life Sciences

It takes seeing things in a different light to break out of a rut. So, oftentimes when a teacher, a friend, a business partner, a relative, or even a stranger provides that one piece of much needed insight, the proverbial light bulb goes off. It is then possible to finally move forward and start experiencing life in new ways.

As healthcare providers enter into value-based care models, they need to break out of their long-held patterns – and strive to make the continual improvements that will help them succeed. But who will flip the switch and enable them to see things in a new light? Life sciences companies can help by offering providers a variety of insights that they simply can’t glean from their own electronic health records (EHR) systems.

Indeed, life sciences companies can support their sales and marketing teams by leveraging the data gathered from a broad range of healthcare organizations and delivering insights to change the way care is delivered on an individual and population basis. By feeding the integrated and standardized data from those disparate healthcare organizations into next-generation predictive analytics, they can develop insights that help providers do things differently. More specifically, these life-sciences teams can:

1. Help providers identify which treatments have proven most effective for patients with isolate or co-morbid conditions. This can help drive better outcomes, while reducing waste, duplication, and the overall cost of care.

2. Enable providers to view their actions in terms of entire populations, not just individual patients. With data about asthma medication sales, along with prescription and claims data obtained from a multitude of providers, life sciences companies can provide a geographical map that displays where asthma “hot spots” exist.

3. Allow providers to determine who might be likely to be affected by certain conditions. By adding Zip+4, demographic, and socioecono mic data into the analytics mix, life sciences companies can create personas that represent segments of the population who share similar attributes and, therefore, are more likely to suffer from similar diseases or conditions.

4. Empower providers to move forward with confidence. By analyzing usage and outcomes data from a broad cross-section of providers, life sciences companies can detail how effective their products have been in managing or resolving a particular condition across specific populations/personas and relative to defined co-morbidities – making it possible to treat patients with greater precision.

These are just a few of the insights that life sciences companies can deliver to their healthcare professional targets, helping them to make enhance the delivery of patient care. Can you think of any others?

This blog was based on “Why Data is the Key to Driving Closer Provider/Life Sciences Collaboration,” an article that appeared in HIT Consultant.

Rate this Article:

Rating: 
Average: 3 (1 vote)

Author
John Pagliuca
Vice President, Life Sciences

John is responsible for leading the commercialization efforts of SCIO’s SaaS solution suite and advanced analytics within the US Life Science vertical. He has more than 15 years of sales, marketing and technology experience, with particular expertise in quantitative analytics and SaaS solutions for Life Sciences.

Read full profile and other posts |

Log in to post comments

SEARCH BLOG

OUR THOUGHT LEADERS

Arun Rangamani
SVP, Care Optimization and SCIOXpert Services


Ben Steverman
Chief Technology Officer


Bob Abrahamson
Vice President, Product Management


David Hom
Chief Evangelist


Dr. Kevin Keck
Chief Medical Officer


Jen Cressman
Vice President, Professional Services


John Pagliuca
Vice President, Life Sciences


Jonathan Niloff, MD (Guest Author)
President, Niloff Healthcare Strategies, LLC


Lalithya Yerramilli
Vice President, Analytics


Lesli Adams, MPA (Guest Author)
Director of Population Health Strategy, Oracle Corporation


Leslie Strader
Project Manager


Linda Pantovic (Guest Author)
Director of Compliance & Risk Adjustment, Scripps Health Plan Services


Mark Feeney
Life Sciences Consultant


Monique Pierce
Vice President, Business Optimization


Nayfe Faillace
Chief Compliance & Privacy Officer


Nicole Cormier
Senior Manager, Home Health


Priyanka Rajkumar
VP - SCIOXpert and Solutions, Analytics


Rachel Hall
Senior Business Analyst


Rena Bielinski
SVP, Strategic Accounts


Rodger Smith
SVP, Payment Integrity


Rose Higgins
President, North America


Subha Vaidyanathan
VP, Technology and Data Management


Taryn Bevilacqua
Compliance Director


Tom Peterson
SVP, Risk Adjustment


ARCHIVES

Sign up to receive the latest SCIO news & insights, industry updates, event updates and more, right in your inbox.